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Rationale
In Southern Europe Pru p3 is the primary sensitizer of
plants fruit and responsible for severe reactions. Specific
immunotherapy (SIT) brings a new perspective to treat
those patients. The aim was to evaluate the effect of sub-
lingual immunotherapy (SLIT) to peach in allergic patients
with systemic symptoms.
Methods
Forty-six peach allergic patients confirmed as positive by
skin test, ImmunoCAP IgE and/or a double-blind placebo-
controlled food-challenge (DBPCFC) were included. After
one year of treatment we evaluated peach tolerance with
DBPCFC using 5, 40, and 120 g of fresh peach with a
mixture of yogurt, orange juice, coffee dried, coconut, and
oatmeal flakes. Placebo meals consisted of the same ingre-
dients, without fresh apple.
Results
From the total group, 21 patients (45%) had anaphylaxis
and 25 (55%) urticaria and/or angioedema. The 82,6%
showed sensitization to other plant foods proteins and
69,5% showed sensitization to pollens. The DBPCFC
was performed in 20 patients who completed the first
year of SLIT. The 90% patients had good tolerance to
peach during DBPCFC as well as fresh peach at home.
Only 2 patients (10%) presented reactions. One patient
suffered an anaphylactic reaction after 45 g of the active
mixture, and other patient suffered angioedema after
ingest complete peach at home.
Conclusion
These results showed a high percentage of patients who
tolerated peach after one year receiving SLIT. There
were no differences in the clinical patterns between the
patients with good response and those patients with
reactions.
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